Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.

Saved in:
Bibliographic Details
Title: Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.
Authors: Schieber T; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. T96249@kumc.edu., Brunk K; National Community Oncology Dispensing Association, 9 Albany St #2e, Cazenovia, NY, 13035, United States of America., Clennon A; Aurora St Luke's Medical Center, 2900 W Oklahoma Ave, Milwaukee, WI, 53215, United States of America., Woolbright BL; Department of Biostatistics and Data Science, University of Kansas Medical Center, 3901 Rainbow Blvd Mailstop 1026, Kansas City, KS, 66103, United States of America., Bantis LE; Department of Biostatistics and Data Science, University of Kansas Medical Center, 3901 Rainbow Blvd Mailstop 1026, Kansas City, KS, 66103, United States of America., Grauer D; The University of Kansas School of Pharmacy, 2010 Becker Dr, Lawrence, KS, 66047, United States of America., Cheng T; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America., Abbasi S; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America., Wulff-Burchfield E; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America., Parikh R; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America., Li H; The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America. hli6@kumc.edu.
Source: Experimental hematology & oncology [Exp Hematol Oncol] 2025 Mar 12; Vol. 14 (1), pp. 36. Date of Electronic Publication: 2025 Mar 12.
Publication Type: Letter
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-3619
DOI:10.1186/s40164-025-00629-4